10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.
CIK: 1622996
File #: 000-55643
Balance Sheet
27 line items · 2 periods
XBRL
| Item | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
Balance Sheets | ||
ASSETS | ||
Current Assets | ||
Cash | 4,323 | 476 |
Other Non-Operating Current Assets | 0 | 4,600 |
Total Current Assets | 4,323 | 5,076 |
Operating Lease Right-of-Use Asset | 0 | 26,898 |
TOTAL ASSETS | 4,323 | 31,974 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
Current Liabilities | ||
Accounts Payable | 116,582 | 154,460 |
Other Current Liabilities | 20,000 | 20,000 |
Due to related parties | 300,360 | 125,588 |
CEO | 1,100 | — |
Operating Lease Liability, Current | 0 | 26,898 |
Total Current and Total Liabilities | 436,942 | 326,946 |
Stockholders' Deficit | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 60,042 | 60,042 |
Total Stockholders' Equity | 32,308,806 | 32,302,781 |
Total Stockholders' Equity | (32,801,467) | (32,657,795) |
Total Stockholders' Deficit | (432,619) | (294,972) |
Accumulated Deficit | (32,801,467) | (32,657,795) |
Additional Paid-In Capital | 32,308,806 | 32,302,781 |
Common Stock | 60,042 | 60,042 |
Preferred Stock | 0 | 0 |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 4,323 | 31,974 |